Home » Cadila Receives U.S. FDA Warning for Manufacturing Violations
Cadila Receives U.S. FDA Warning for Manufacturing Violations
The Ahmedabad-based pharmaceutical company Zydus Cadila said it had received a warning letter from the FDA over violations of current good manufacturing practices or cGMP regulations for finished pharmaceuticals at its Moraiya facility near Ahmedabad, reports said.
RTTNews
RTTNews
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May